MARKET VISIT
TO JAPAN
BIOJAPAN2015: YOKOHAMA
12 – 16 OCTOBER 2015
SECTORS: LIFE SCIENCE WITH A PARTICULAR FOCUS ON: REGENERATIVE MEDICINE CELL THERAPY, IMMUNO ONCOLOGY AND CLINICAL TRIALS
APPLICATION DEADLINE DATE: MONDAY 14 SEPTEMBER 2015
The Market Visit to Japan, organised by the Mayor’s Export Programme, in partnership with the London
Chamber of Commerce and Industry (LCCI) offers London businesses the opportunity to attend Bio
Japan - Asia's premier event for the global biotechnology industry.
In 2010, almost a quarter of Japan’s 127 million people were over 65 representing one of the world’s
fastest growing elderly populations. Research shows that this is likely to increase to over 30% by 2025
and to 40% by 2055. As a result, Japanese society is facing an increasing number of chronic and
long-term diseases, driving huge growth in Japan’s Life Sciences market.
Japan, after the US, has the second largest healthcare, pharmaceutical and medical devices markets in
the world. Total medical expenditure is over £250 billion a year and the Japanese pharmaceutical market
is bigger than both France and Germany's combined.
UK bio companies are in as strong positon to supply Japan’s healthcare market where unique,
sophisticated, and highly technical products are sought after to assist the growing population.
Opportunities exist in medical devices in advanced and innovative products for exports of finished
products, joint R&D and technology licensing-out. For companies in pharmaceuticals demand for joint
development, outsourcing of R&D, clinical trials and regulatory aairs to Europe continue to increase.
ABOUT BIO JAPAN 2015
BioJapan is Asia's premier partnering event for the global biotechnology industry. With over 100
exhibitors, Japan’s top business development and licensing professionals, alliance management
professionals, R&D personnel and biotech company executives will gather in Yokohama for the three
day exhibition.
STRENGTHS OF THE
JAPAN BIOTECHNOLOGY
MARKET AND RECENT
DEVELOPMENTS:
INCENTIVES FOR BRITISH
BUSINESSES EXPORTING TO
JAPAN:
•The life sciences sector is viewed as a key engine for Japan’s economic growth
•A stable place to do business
•The Japanese government will expand the life sciences market (pharma, medical devices and regenerative medicine) by approximately 30% from $120 billion to $160 billion by 2020
•The Ministry of Economy, Trade and Industry (MEIT) estimates the market size for regenerative medicine will grow to $25 billion by 2050
•A strategic stepping stone for other Asian markets
•Strong political, trade and social ties between the 2 countries
•A highly educated consumers who are early adopters of new products and services
•A large and rich consumer market based in urban areas
•In November 2014, the Act on Safety of Regenerative Medicine came into force and has built momentum for practical medicine under the Pharmaceutical and Medical Device Affairs Law in Japan
•Tokyo conurbation is the world’s largest at around 35 million
•The new legal framework provides an impetus to the commercialisation of regenerative medicine products in Japan
•An increasingly globalised outlook
•A huge, open economy
•A cutting edge business culture
•Strong intellectual property (IP)
protection
•Japan is one of the world’s most radical regulatory regime for cell therapies, exempting companies from the need to conduct long, expensive clinical trials before offering new treatments to patients
WHO SHOULD CONSIDER JOINING THIS
MISSION
COMPANIES IN LIFE SCIENCE: REGENERATIVE MEDICINE; CELL
THERAPY; IMMUNO ONCOLOGY AND CLINICAL TRIALS
THE BENEFITS OF JOINING
THIS MISSION
•Access to the Mayor’s Export Programme at BioJapan 2015.
•Participation in networking events and seminars with potential clients and parners
•Pre-visit and in-country briefings providing market information and advice on how to do business in Japan
•Extensive PR opportunities by being part of a high profile market visit led by a VIP
•Company profile in the trade visit brochure distributed to companies in Japan
•Shared intelligence through group visit
•Services of experienced Market Visit
Managers
•Competitive cost through group travel
PROGRAMME
DAY
TIME
PROGRAMME
Sun 11 Oct
Depart London Heathrow
Mon 12 Oct
Arrive in Tokyo
Japan bank holiday – free day
Tue 13 Oct
Wed 14 Oct
Hotel tbc
AM
Transfer to Yokohama
PM
Site visit and Event at King Skyfront
AM
Exhibiting at BioJapan 2015
Location tbc
PM
Exclusive access to the VIP opening ceremony of
BioJapan
Osanbashi Hall
Thu 15 Oct
Exhibiting at BioJapan 2015
Fri 15 Oct
Exhibiting at BioJapan 2015
The programme is not finalised and may be subject to change.
THE COSTS
•Companies are required to pay an administration fee of £250 (+VAT) to attend this Market Visit
•Travel Package: A competitive travel package will be available which will include internal
transfers and hotels
LONDON CHAMBER OF COMMERCE AND
INDUSTRY
London Chamber of Commerce and Industry (LCCI) is the UK’s leading chamber of commerce. Its
International Business Team promotes the business interests of SMEs in the international marketplace
through a comprehensive programme of international seminars, training courses and missions. Whether
a business is already trading internationally or plans to do so in the future, the programme is designed
to help companies open up new markets for their products and services.
LONDON & PARTNERS
London & Partners is the official promotional organisation for London. We work on behalf of the Mayor
of London and all Londoners to build London’s reputation as the most exciting city in which to invest,
grow your business through exporting, visit, meet, study, live and work in order to create jobs and
economic growth.
ELIGIBILITY
•To accompany this trade mission, your business must be a small or medium sized enterprise (SME), based within one of London’s 33 boroughs.
•An SME company is defined as having an annual turnover of less than £40 million and fewer than 250 employees.
•SMEs should be working primarily in Life Science: Regenerative Medicine; Cell Therapy; Immuno Oncology and Clinical Trials.
HOW TO APPLY
For the full application
pack, please contact the
Market Visit Manager
Ruma Deb
Senior International Business Executive, London Chamber
of Commerce and Industry.
E: [email protected]
T: +44 (0)20 7203 1949.
CONDITIONS AND DATA PROTECTION
If circumstances change and your organisation’s services or products are no longer suitable for export, or no longer meet the Mayor’s Export
Programme eligibility criteria LCCI reserves the right to withdraw support.
The Mayor’s Export Programme and LCCI will only use your personal data fairly and lawfully and will take all reasonable measures to ensure
that it is accurate and up to date and ensure it does not retain it any longer than necessary and that it is protected from destruction, loss,
alteration, unauthorised disclosure or other unlawful use.
You have the right to request and be provided with a copy of the information we hold about you, and to have any inaccuracies amended. The
information provided will be treated in the strictest confidence. Information regarding the use and processing of personal data is to be found
in the privacy statement at the Greater London Authority’s website www.london.gov.uk.
The Mayor’s Export Programme and LCCI would like to send you news and event information, please tick here if you prefer not to receive
this information by email [ ].